BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18589358)

  • 1. Plasma DNA is more reliable than carcinoembryonic antigen for diagnosis of recurrent esophageal cancer.
    Banki F; Yacoub WN; Hagen JA; Mason RJ; Ayazi S; DeMeester SR; Lipham JC; Danenberg K; Danenberg P; DeMeester TR
    J Am Coll Surg; 2008 Jul; 207(1):30-5. PubMed ID: 18589358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma DNA as a molecular marker for completeness of resection and recurrent disease in patients with esophageal cancer.
    Banki F; Mason RJ; Oh D; Hagen JA; DeMeester SR; Lipham JC; Tanaka K; Danenberg KD; Yacoub WN; Danenberg PV; DeMeester TR
    Arch Surg; 2007 Jun; 142(6):533-8; discussion 538-9. PubMed ID: 17576889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of circulating tumor cells in blood by molecular detection and tumor markers in esophageal cancer.
    Nakashima S; Natsugoe S; Matsumoto M; Miyazono F; Nakajo A; Uchikura K; Tokuda K; Ishigami S; Baba M; Takao S; Aikou T
    Surgery; 2003 Feb; 133(2):162-9. PubMed ID: 12605177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoembryonic antigen messenger RNA expression in blood predicts recurrence in esophageal cancer.
    Setoyama T; Natsugoe S; Okumura H; Matsumoto M; Uchikado Y; Ishigami S; Owaki T; Takao S; Aikou T
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5972-7. PubMed ID: 17062668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer.
    Gaspar MJ; Diez M; Rodriguez A; Ratia T; Martin Duce A; Galvan M; Granell J; Coca C
    Anticancer Res; 2003; 23(4):3427-32. PubMed ID: 12926084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic application of detecting AgNOR in peripheral blood T lymphocyte in patients with esophageal carcinoma].
    Wang JY; Rong TH; Liang YR; Long H; Chen QL; Ma GW
    Ai Zheng; 2004 May; 23(5):577-80. PubMed ID: 15142458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: a receiver operating characteristic curve analysis.
    Körner H; Söreide K; Stokkeland PJ; Söreide JA
    Ann Surg Oncol; 2007 Feb; 14(2):417-23. PubMed ID: 17103264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A small rise in CEA is sensitive for recurrence after surgery for colorectal cancer.
    Irvine T; Scott M; Clark CI
    Colorectal Dis; 2007 Jul; 9(6):527-31. PubMed ID: 17573747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and quantification of circulating tumor cells in patients with esophageal cancer by real-time polymerase chain reaction.
    Ito H; Kanda T; Nishimaki T; Sato H; Nakagawa S; Hatakeyama K
    J Exp Clin Cancer Res; 2004 Sep; 23(3):455-64. PubMed ID: 15595636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of CEA, SCC and Cyfra21-1 serum test in esophageal cancer].
    Mao YS; Zhang DC; Zhao XH; Wang LJ; Qi J; Li XX
    Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):457-60. PubMed ID: 14575569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carcinoembryonic antigen in diagnosis and monitoring of colorectal cancer].
    Forones NM; Tanaka M; Machado D; Falcão JB; Giovanoni M
    Arq Gastroenterol; 1997; 34(1):3-6. PubMed ID: 9458953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EIA versus RIA in detecting carcinoembryonic antigen level of patients with metastatic colorectal cancer.
    Wang WS; Lin JK; Lin TC; Chiou TJ; Liu JH; Yen CC; Chen WS; Jiang JK; Yang SH; Wang HS; Chen PM
    Hepatogastroenterology; 2004; 51(55):136-41. PubMed ID: 15011849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoembryonic antigen messenger RNA expression in blood can predict relapse in gastric cancer.
    Ishigami S; Sakamoto A; Uenosono Y; Nakajo A; Okumura H; Matsumoto M; Setoyama T; Arigami T; Uchikado Y; Arima H; Natsugoe S; Aikou T
    J Surg Res; 2008 Aug; 148(2):205-9. PubMed ID: 17936797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early prediction of tumor recurrence after curative resection of gastric carcinoma by measuring soluble E-cadherin.
    Chan AO; Chu KM; Lam SK; Cheung KL; Law S; Kwok KF; Wong WM; Yuen MF; Wong BC
    Cancer; 2005 Aug; 104(4):740-6. PubMed ID: 15991243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum carcinoembryonic antigen level is associated with epidermal growth factor receptor mutations in recurrent lung adenocarcinomas.
    Shoji F; Yoshino I; Yano T; Kometani T; Ohba T; Kouso H; Takenaka T; Miura N; Okazaki H; Maehara Y
    Cancer; 2007 Dec; 110(12):2793-8. PubMed ID: 17941001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients.
    Mroczko B; Kozłowski M; Groblewska M; Łukaszewicz M; Nikliński J; Jelski W; Laudański J; Chyczewski L; Szmitkowski M
    Clin Chim Acta; 2008 Mar; 389(1-2):61-6. PubMed ID: 18155162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study.
    Guadagni F; Ferroni P; Carlini S; Mariotti S; Spila A; Aloe S; D'Alessandro R; Carone MD; Cicchetti A; Ricciotti A; Venturo I; Perri P; Di Filippo F; Cognetti F; Botti C; Roselli M
    Clin Cancer Res; 2001 Aug; 7(8):2357-62. PubMed ID: 11489813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative serum carcinoembryonic antigen has insufficient accuracy for excluding recurrence from patients with Dukes C colorectal cancer: analysis with likelihood ratio and posttest probability in a follow-up study.
    Hara M; Kanemitsu Y; Hirai T; Komori K; Kato T
    Dis Colon Rectum; 2008 Nov; 51(11):1675-80. PubMed ID: 18633674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The miniscule benefit of serial carcinoembryonic antigen monitoring after effective curative treatment for primary colorectal cancer.
    Wolf RF; Cohen AM
    J Am Coll Surg; 1997 Jul; 185(1):60-4. PubMed ID: 9208962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.